CAM-HER2-Ac225

N/A

Report date: 2025/11/05 17:48:34

Base Information

Drug NameCAM-HER2-Ac225

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 binders

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsGastroesophageal Junction NeoplasmsStomach NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPrecirix NV/SA

China Registration ClassN/A

Develop Information

Active CompaniesPrecirix NV/SA

Inactive CompaniesN/A

Active IndicationsGastroesophageal Junction NeoplasmsStomach NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A